The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

The Cancer Genome Atlas Research Network

doi:10.1016/j.celrep.2018.03.075

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

The Cancer Genome Atlas Research Network

School of Biomedical Sciences

Research output: Contribution to journal › Article

118 Citations (Scopus)

Abstract

Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers with different genetic drivers, clinical courses, and therapeutic responses. The current study evaluated 843 RCC from the three major histologic subtypes, including 488 clear cell RCC, 274 papillary RCC, and 81 chromophobe RCC. Comprehensive genomic and phenotypic analysis of the RCC subtypes reveals distinctive features of each subtype that provide the foundation for the development of subtype-specific therapeutic and management strategies for patients affected with these cancers. Somatic alteration of BAP1, PBRM1, and PTEN and altered metabolic pathways correlated with subtype-specific decreased survival, while CDKN2A alteration, increased DNA hypermethylation, and increases in the immune-related Th2 gene expression signature correlated with decreased survival within all major histologic subtypes. CIMP-RCC demonstrated an increased immune signature, and a uniform and distinct metabolic expression pattern identified a subset of metabolically divergent (MD) ChRCC that associated with extremely poor survival. Ricketts et al. find distinctive features of each RCC subtype, providing the foundation for development of subtype-specific therapeutic and management strategies. Somatic alteration of BAP1, PBRM1, and metabolic pathways correlates with subtype-specific decreased survival, while CDKN2A alteration, DNA hypermethylation, and Th2 immune signature correlate with decreased survival within all subtypes.

Original language	English
Pages (from-to)	313-326.e5
Journal	Cell Reports
Volume	23
Issue number	1
DOIs	https://doi.org/10.1016/j.celrep.2018.03.075
Publication status	Published - 3 Apr 2018

Access to Document

10.1016/j.celrep.2018.03.075Licence: CC BY

Link to publication in Scopus

Fingerprint Dive into the research topics of 'The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma'. Together they form a unique fingerprint.

Cite this

The Cancer Genome Atlas Research Network (2018). The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports, 23(1), 313-326.e5. https://doi.org/10.1016/j.celrep.2018.03.075

@article{56328d9d36424657969b9245e9a3793b,

title = "The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma",

abstract = "Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers with different genetic drivers, clinical courses, and therapeutic responses. The current study evaluated 843 RCC from the three major histologic subtypes, including 488 clear cell RCC, 274 papillary RCC, and 81 chromophobe RCC. Comprehensive genomic and phenotypic analysis of the RCC subtypes reveals distinctive features of each subtype that provide the foundation for the development of subtype-specific therapeutic and management strategies for patients affected with these cancers. Somatic alteration of BAP1, PBRM1, and PTEN and altered metabolic pathways correlated with subtype-specific decreased survival, while CDKN2A alteration, increased DNA hypermethylation, and increases in the immune-related Th2 gene expression signature correlated with decreased survival within all major histologic subtypes. CIMP-RCC demonstrated an increased immune signature, and a uniform and distinct metabolic expression pattern identified a subset of metabolically divergent (MD) ChRCC that associated with extremely poor survival. Ricketts et al. find distinctive features of each RCC subtype, providing the foundation for development of subtype-specific therapeutic and management strategies. Somatic alteration of BAP1, PBRM1, and metabolic pathways correlates with subtype-specific decreased survival, while CDKN2A alteration, DNA hypermethylation, and Th2 immune signature correlate with decreased survival within all subtypes.",

keywords = "CDKN2A, chromatin remodeling, chromophobe renal cell carcinoma, clear cell renal cell carcinoma, DNA hypermethylation, immune signature, PanCanAtlas, papillary renal cell carcinoma, TCGA",

author = "{The Cancer Genome Atlas Research Network} and Ricketts, {Christopher J.} and {De Cubas}, {Aguirre A.} and Huihui Fan and Smith, {Christof C.} and Martin Lang and Ed Reznik and Reanne Bowlby and Gibb, {Ewan A.} and Rehan Akbani and Rameen Beroukhim and Bottaro, {Donald P.} and Choueiri, {Toni K.} and Gibbs, {Richard A.} and Godwin, {Andrew K.} and Scott Haake and Hakimi, {A. Ari} and Henske, {Elizabeth P.} and Hsieh, {James J.} and Ho, {Thai H.} and Kanchi, {Rupa S.} and Bhavani Krishnan and Kwaitkowski, {David J.} and Wembin Lui and Merino, {Maria J.} and Mills, {Gordon B.} and Jerome Myers and Nickerson, {Michael L.} and Reuter, {Victor E.} and Schmidt, {Laura S.} and Shelley, {C. Simon} and Hui Shen and Brian Shuch and Sabina Signoretti and Ramaprasad Srinivasan and Pheroze Tamboli and George Thomas and Vincent, {Benjamin G.} and Vocke, {Cathy D.} and Wheeler, {David A.} and Lixing Yang and Kim, {William T.} and Robertson, {A. Gordon} and Caesar-Johnson, {Samantha J.} and Demchok, {John A.} and Ina Felau and Melpomeni Kasapi and Ferguson, {Martin L.} and Hutter, {Carolyn M.} and Sofia, {Heidi J.} and Roy Tarnuzzer and Zhining Wang and Zenklusen, {Jean C.} and Zhang, {Jiashan (Julia)} and Sudha Chudamani and Jia Liu and Laxmi Lolla and Rashi Naresh and Todd Pihl and Qiang Sun and Yunhu Wan and Ye Wu and Juok Cho and Timothy DeFreitas and Scott Frazer and Nils Gehlenborg and Gad Getz and Heiman, {David I.} and Jaegil Kim and Lawrence, {Michael S.} and Pei Lin and Sam Meier and Noble, {Michael S.} and Gordon Saksena and Doug Voet and Hongzheng Zhang and Brady Bernard and Nyasha Chambwe and Varsha Dhankani and Theo Knijnenburg and Roger Kramer and Kalle Leinonen and Yuexin Liu and Michael Miller and Sheila Reynolds and Ilya Shmulevich and Vesteinn Thorsson and Wei Zhang and Broom, {Bradley M.} and Hegde, {Apurva M.} and Zhenlin Ju and Anil Korkut and Jun Li and Han Liang and Shiyun Ling and Wenbin Liu and Yiling Lu and Ng, {Kwok Shing} and Arvind Rao and Michael Ryan and Jioajiao Wang and Weinstein, {John N.} and Jiexin Zhang and Adam Abeshouse and Joshua Armenia and Debyani Chakravarty and Chatila, {Walid K.} and {de Bruijn}, Ino and Jianjiong Gao and Gross, {Benjamin E.} and Heins, {Zachary J.} and Ritika Kundra and Konnor La and Marc Ladanyi and Augustin Luna and Nissan, {Moriah G.} and Angelica Ochoa and Phillips, {Sarah M.} and Francisco Sanchez-Vega and Chris Sander and Nikolaus Schultz and Robert Sheridan and Sumer, {S. Onur} and Yichao Sun and Taylor, {Barry S.} and Pavana Anur and Myron Peto and Paul Spellman and Christopher Benz and Stuart, {Joshua M.} and Wong, {Christopher K.} and Christina Yau and Hayes, {D. Neil} and Parker, {Joel S.} and Wilkerson, {Matthew D.} and Adrian Ally and Miruna Balasundaram and Denise Brooks and Rebecca Carlsen and Eric Chuah and Noreen Dhalla and Robert Holt and Jones, {Steven J.M.} and Katayoon Kasaian and Darlene Lee and Yussanne Ma and Marra, {Marco A.} and Michael Mayo and Moore, {Richard A.} and Mungall, {Andrew J.} and Karen Mungall and Robertson, {A. Gordon} and Sara Sadeghi and Schein, {Jacqueline E.} and Payal Sipahimalani and Angela Tam and Nina Thiessen and Kane Tse and Tina Wong and Berger, {Ashton C.} and Cherniack, {Andrew D.} and Carrie Cibulskis and Gabriel, {Stacey B.} and Gao, {Galen F.} and Gavin Ha and Matthew Meyerson and Schumacher, {Steven E.} and Juliann Shih and Kucherlapati, {Melanie H.} and Kucherlapati, {Raju S.} and Stephen Baylin and Leslie Cope and Ludmila Danilova and Bootwalla, {Moiz S.} and Lai, {Phillip H.} and Maglinte, {Dennis T.} and {Van Den Berg}, {David J.} and Weisenberger, {Daniel J.} and Auman, {J. Todd} and Saianand Balu and Tom Bodenheimer and Cheng Fan and Hoadley, {Katherine A.} and Hoyle, {Alan P.} and Jefferys, {Stuart R.} and Jones, {Corbin D.} and Shaowu Meng and Mieczkowski, {Piotr A.} and Mose, {Lisle E.} and Perou, {Amy H.} and Perou, {Charles M.} and Jeffrey Roach and Yan Shi and Simons, {Janae V.} and Tara Skelly and Soloway, {Matthew G.} and Donghui Tan and Umadevi Veluvolu and Toshinori Hinoue and Laird, {Peter W.} and Wanding Zhou and Michelle Bellair and Kyle Chang and Kyle Covington and Creighton, {Chad J.} and Huyen Dinh and Doddapaneni, {Harsha Vardhan} and Donehower, {Lawrence A.} and Jennifer Drummond and Robert Glenn and Walker Hale and Yi Han and Jianhong Hu and Viktoriya Korchina and Sandra Lee and Lora Lewis and Wei Li and Xiuping Liu and Margaret Morgan and Donna Morton and Donna Muzny and Jireh Santibanez and Margi Sheth and Eve Shinbrot and Linghua Wang and Min Wang and Liu Xi and Fengmei Zhao and Julian Hess and Appelbaum, {Elizabeth L.} and Matthew Bailey and Cordes, {Matthew G.} and Li Ding and Fronick, {Catrina C.} and Fulton, {Lucinda A.} and Fulton, {Robert S.} and Cyriac Kandoth and Mardis, {Elaine R.} and McLellan, {Michael D.} and Miller, {Christopher A.} and Schmidt, {Heather K.} and Wilson, {Richard K.} and Daniel Crain and Erin Curley and Johanna Gardner and Kevin Lau and David Mallery and Scott Morris and Joseph Paulauskis and Robert Penny and Jenette Creaney",

year = "2018",

month = apr,

day = "3",

doi = "10.1016/j.celrep.2018.03.075",

language = "English",

volume = "23",

pages = "313--326.e5",

journal = "Cell Reports",

issn = "2211-1247",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

AU - The Cancer Genome Atlas Research Network

AU - Ricketts, Christopher J.

AU - De Cubas, Aguirre A.

AU - Fan, Huihui

AU - Smith, Christof C.

AU - Lang, Martin

AU - Reznik, Ed

AU - Bowlby, Reanne

AU - Gibb, Ewan A.

AU - Akbani, Rehan

AU - Beroukhim, Rameen

AU - Bottaro, Donald P.

AU - Choueiri, Toni K.

AU - Gibbs, Richard A.

AU - Godwin, Andrew K.

AU - Haake, Scott

AU - Hakimi, A. Ari

AU - Henske, Elizabeth P.

AU - Hsieh, James J.

AU - Ho, Thai H.

AU - Kanchi, Rupa S.

AU - Krishnan, Bhavani

AU - Kwaitkowski, David J.

AU - Lui, Wembin

AU - Merino, Maria J.

AU - Mills, Gordon B.

AU - Myers, Jerome

AU - Nickerson, Michael L.

AU - Reuter, Victor E.

AU - Schmidt, Laura S.

AU - Shelley, C. Simon

AU - Shen, Hui

AU - Shuch, Brian

AU - Signoretti, Sabina

AU - Srinivasan, Ramaprasad

AU - Tamboli, Pheroze

AU - Thomas, George

AU - Vincent, Benjamin G.

AU - Vocke, Cathy D.

AU - Wheeler, David A.

AU - Yang, Lixing

AU - Kim, William T.

AU - Robertson, A. Gordon

AU - Caesar-Johnson, Samantha J.

AU - Demchok, John A.

AU - Felau, Ina

AU - Kasapi, Melpomeni

AU - Ferguson, Martin L.

AU - Hutter, Carolyn M.

AU - Sofia, Heidi J.

AU - Tarnuzzer, Roy

AU - Wang, Zhining

AU - Zenklusen, Jean C.

AU - Zhang, Jiashan (Julia)

AU - Chudamani, Sudha

AU - Liu, Jia

AU - Lolla, Laxmi

AU - Naresh, Rashi

AU - Pihl, Todd

AU - Sun, Qiang

AU - Wan, Yunhu

AU - Wu, Ye

AU - Cho, Juok

AU - DeFreitas, Timothy

AU - Frazer, Scott

AU - Gehlenborg, Nils

AU - Getz, Gad

AU - Heiman, David I.

AU - Kim, Jaegil

AU - Lawrence, Michael S.

AU - Lin, Pei

AU - Meier, Sam

AU - Noble, Michael S.

AU - Saksena, Gordon

AU - Voet, Doug

AU - Zhang, Hongzheng

AU - Bernard, Brady

AU - Chambwe, Nyasha

AU - Dhankani, Varsha

AU - Knijnenburg, Theo

AU - Kramer, Roger

AU - Leinonen, Kalle

AU - Liu, Yuexin

AU - Miller, Michael

AU - Reynolds, Sheila

AU - Shmulevich, Ilya

AU - Thorsson, Vesteinn

AU - Zhang, Wei

AU - Broom, Bradley M.

AU - Hegde, Apurva M.

AU - Ju, Zhenlin

AU - Korkut, Anil

AU - Li, Jun

AU - Liang, Han

AU - Ling, Shiyun

AU - Liu, Wenbin

AU - Lu, Yiling

AU - Ng, Kwok Shing

AU - Rao, Arvind

AU - Ryan, Michael

AU - Wang, Jioajiao

AU - Weinstein, John N.

AU - Zhang, Jiexin

AU - Abeshouse, Adam

AU - Armenia, Joshua

AU - Chakravarty, Debyani

AU - Chatila, Walid K.

AU - de Bruijn, Ino

AU - Gao, Jianjiong

AU - Gross, Benjamin E.

AU - Heins, Zachary J.

AU - Kundra, Ritika

AU - La, Konnor

AU - Ladanyi, Marc

AU - Luna, Augustin

AU - Nissan, Moriah G.

AU - Ochoa, Angelica

AU - Phillips, Sarah M.

AU - Sanchez-Vega, Francisco

AU - Sander, Chris

AU - Schultz, Nikolaus

AU - Sheridan, Robert

AU - Sumer, S. Onur

AU - Sun, Yichao

AU - Taylor, Barry S.

AU - Anur, Pavana

AU - Peto, Myron

AU - Spellman, Paul

AU - Benz, Christopher

AU - Stuart, Joshua M.

AU - Wong, Christopher K.

AU - Yau, Christina

AU - Hayes, D. Neil

AU - Parker, Joel S.

AU - Wilkerson, Matthew D.

AU - Ally, Adrian

AU - Balasundaram, Miruna

AU - Brooks, Denise

AU - Carlsen, Rebecca

AU - Chuah, Eric

AU - Dhalla, Noreen

AU - Holt, Robert

AU - Jones, Steven J.M.

AU - Kasaian, Katayoon

AU - Lee, Darlene

AU - Ma, Yussanne

AU - Marra, Marco A.

AU - Mayo, Michael

AU - Moore, Richard A.

AU - Mungall, Andrew J.

AU - Mungall, Karen

AU - Robertson, A. Gordon

AU - Sadeghi, Sara

AU - Schein, Jacqueline E.

AU - Sipahimalani, Payal

AU - Tam, Angela

AU - Thiessen, Nina

AU - Tse, Kane

AU - Wong, Tina

AU - Berger, Ashton C.

AU - Cherniack, Andrew D.

AU - Cibulskis, Carrie

AU - Gabriel, Stacey B.

AU - Gao, Galen F.

AU - Ha, Gavin

AU - Meyerson, Matthew

AU - Schumacher, Steven E.

AU - Shih, Juliann

AU - Kucherlapati, Melanie H.

AU - Kucherlapati, Raju S.

AU - Baylin, Stephen

AU - Cope, Leslie

AU - Danilova, Ludmila

AU - Bootwalla, Moiz S.

AU - Lai, Phillip H.

AU - Maglinte, Dennis T.

AU - Van Den Berg, David J.

AU - Weisenberger, Daniel J.

AU - Auman, J. Todd

AU - Balu, Saianand

AU - Bodenheimer, Tom

AU - Fan, Cheng

AU - Hoadley, Katherine A.

AU - Hoyle, Alan P.

AU - Jefferys, Stuart R.

AU - Jones, Corbin D.

AU - Meng, Shaowu

AU - Mieczkowski, Piotr A.

AU - Mose, Lisle E.

AU - Perou, Amy H.

AU - Perou, Charles M.

AU - Roach, Jeffrey

AU - Shi, Yan

AU - Simons, Janae V.

AU - Skelly, Tara

AU - Soloway, Matthew G.

AU - Tan, Donghui

AU - Veluvolu, Umadevi

AU - Hinoue, Toshinori

AU - Laird, Peter W.

AU - Zhou, Wanding

AU - Bellair, Michelle

AU - Chang, Kyle

AU - Covington, Kyle

AU - Creighton, Chad J.

AU - Dinh, Huyen

AU - Doddapaneni, Harsha Vardhan

AU - Donehower, Lawrence A.

AU - Drummond, Jennifer

AU - Glenn, Robert

AU - Hale, Walker

AU - Han, Yi

AU - Hu, Jianhong

AU - Korchina, Viktoriya

AU - Lee, Sandra

AU - Lewis, Lora

AU - Li, Wei

AU - Liu, Xiuping

AU - Morgan, Margaret

AU - Morton, Donna

AU - Muzny, Donna

AU - Santibanez, Jireh

AU - Sheth, Margi

AU - Shinbrot, Eve

AU - Wang, Linghua

AU - Wang, Min

AU - Xi, Liu

AU - Zhao, Fengmei

AU - Hess, Julian

AU - Appelbaum, Elizabeth L.

AU - Bailey, Matthew

AU - Cordes, Matthew G.

AU - Ding, Li

AU - Fronick, Catrina C.

AU - Fulton, Lucinda A.

AU - Fulton, Robert S.

AU - Kandoth, Cyriac

AU - Mardis, Elaine R.

AU - McLellan, Michael D.

AU - Miller, Christopher A.

AU - Schmidt, Heather K.

AU - Wilson, Richard K.

AU - Crain, Daniel

AU - Curley, Erin

AU - Gardner, Johanna

AU - Lau, Kevin

AU - Mallery, David

AU - Morris, Scott

AU - Paulauskis, Joseph

AU - Penny, Robert

AU - Creaney, Jenette

PY - 2018/4/3

Y1 - 2018/4/3

N2 - Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers with different genetic drivers, clinical courses, and therapeutic responses. The current study evaluated 843 RCC from the three major histologic subtypes, including 488 clear cell RCC, 274 papillary RCC, and 81 chromophobe RCC. Comprehensive genomic and phenotypic analysis of the RCC subtypes reveals distinctive features of each subtype that provide the foundation for the development of subtype-specific therapeutic and management strategies for patients affected with these cancers. Somatic alteration of BAP1, PBRM1, and PTEN and altered metabolic pathways correlated with subtype-specific decreased survival, while CDKN2A alteration, increased DNA hypermethylation, and increases in the immune-related Th2 gene expression signature correlated with decreased survival within all major histologic subtypes. CIMP-RCC demonstrated an increased immune signature, and a uniform and distinct metabolic expression pattern identified a subset of metabolically divergent (MD) ChRCC that associated with extremely poor survival. Ricketts et al. find distinctive features of each RCC subtype, providing the foundation for development of subtype-specific therapeutic and management strategies. Somatic alteration of BAP1, PBRM1, and metabolic pathways correlates with subtype-specific decreased survival, while CDKN2A alteration, DNA hypermethylation, and Th2 immune signature correlate with decreased survival within all subtypes.

AB - Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers with different genetic drivers, clinical courses, and therapeutic responses. The current study evaluated 843 RCC from the three major histologic subtypes, including 488 clear cell RCC, 274 papillary RCC, and 81 chromophobe RCC. Comprehensive genomic and phenotypic analysis of the RCC subtypes reveals distinctive features of each subtype that provide the foundation for the development of subtype-specific therapeutic and management strategies for patients affected with these cancers. Somatic alteration of BAP1, PBRM1, and PTEN and altered metabolic pathways correlated with subtype-specific decreased survival, while CDKN2A alteration, increased DNA hypermethylation, and increases in the immune-related Th2 gene expression signature correlated with decreased survival within all major histologic subtypes. CIMP-RCC demonstrated an increased immune signature, and a uniform and distinct metabolic expression pattern identified a subset of metabolically divergent (MD) ChRCC that associated with extremely poor survival. Ricketts et al. find distinctive features of each RCC subtype, providing the foundation for development of subtype-specific therapeutic and management strategies. Somatic alteration of BAP1, PBRM1, and metabolic pathways correlates with subtype-specific decreased survival, while CDKN2A alteration, DNA hypermethylation, and Th2 immune signature correlate with decreased survival within all subtypes.

KW - CDKN2A

KW - chromatin remodeling

KW - chromophobe renal cell carcinoma

KW - clear cell renal cell carcinoma

KW - DNA hypermethylation

KW - immune signature

KW - PanCanAtlas

KW - papillary renal cell carcinoma

KW - TCGA

UR - http://www.scopus.com/inward/record.url?scp=85044860979&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2018.03.075

DO - 10.1016/j.celrep.2018.03.075

M3 - Article

C2 - 29617669

AN - SCOPUS:85044860979

VL - 23

SP - 313-326.e5

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 1

ER -